Oncologix Tech (OCLG) Return on Equity ROE from the third quarter 2015 to third quarter 2014 and annually, average high and low, overall ranking from May 31 2015 to May 31 2014 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Oncologix Tech Inc.  (OCLG)

Oncologix Tech's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Oncologix Tech in the third quarter 2015?
Due to the lack of equity, it was not possible to calculate Oncologix Tech Inc.'s return on equity (ROE) in its third quarter 2015

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (May 31 2015)
III. Quarter		 (Feb 28 2015)
II. Quarter		 (Nov 30 2014)
I. Quarter		 (Aug 31 2014)
IV. Quarter		 (May 31 2014)
III. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -2 -1 -2 -1 -2
Return On Equity (TTM) - - - - -
OCLG's Total Ranking # # # # #
Equity (TTM) in Millions -1 -1 -1 -1 0
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Back to OCLG Management Effectiveness >> OCLG's 5 Years Annual ROE >> Compare OCLG ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





OCLG Annual Return On Equity (Aug 31 2014)
2014		 (Aug 31 2013)
2013		 (Aug 31 2012)
2012

Total Equity in Millions -1 0 -1 0 0
Y / Y Equity Change - - - - -
Net Income in Millions -1 -1 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity - - - - -

Back to OCLG Management Effectiveness >> OCLG's 5 Years Annual ROE >> Compare OCLG ROE to its Competitors




More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
OCLG's' Return on Equity at Yahoo Finance
OCLG's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for OCLG's Competitors
Subscribers only: Roe for Oncologix Tech's Suppliers
Subscribers only: Return On Equity for OCLG's Customers




Companies with similar Return On Equity at May 31 2015, within Healthcare Sector ROE
Phibro Animal Health Corporation  257.31 %
Adm Tronics Unlimited Inc   239.19 %
Idexx Laboratories Inc  186.44 %
Lifevantage Corp  176.64 %
Enveric Biosciences Inc   154.13 %
Radnet Inc   116.93 %
Gilead Sciences Inc   93.99 %
Sientra Inc   92.94 %
Fonar Corporation  92.90 %
Viskase Holdings inc   86.14 %
Ligand Pharmaceuticals Incorporated  73.32 %
Lumos Pharma Inc   64.61 %
Abbvie Inc   62.83 %
Journey Medical Corp  54.68 %
Supernus Pharmaceuticals inc   52.60 %
Abiomed Inc   51.19 %
Mettler toledo International Inc   48.01 %
Vanda Pharmaceuticals Inc   45.41 %
Teligent Inc   44.26 %
Diversicare Healthcare Services Inc   42.10 %
China Biologic Products Holdings Inc   41.47 %
Pacific Health Care Organization Inc  40.34 %
Catalent Inc   40.10 %
Brainstorm Cell Therapeutics inc   38.60 %
Lannett Company Inc  37.42 %
Amag Pharmaceuticals inc   37.36 %
Encompass Health Corporation  36.91 %
Enanta Pharmaceuticals Inc  36.35 %
3m Company  35.33 %
Celgene Corp  34.63 %

Date modified: 2026-09-08T15:07:54+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.